Third Rock Ventures is a venture capital firm with offices in Boston and San Francisco.[1] Founded in 2007, the firm invests in biotechnology startups.[2]
Funding and investments
Third Rock Ventures has raised $3.8 billion since it was created and invested in more than 60 companies, including Sage Therapeutics, Editas Medicine, Constellation Pharmaceuticals and Flare Therapeutics.[3][4]